Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Syntellix’s MAGNEZIX® implants are clinically proven to be as stable as traditional titanium or stainless steel but offer the unique advantage of being gradually transformed into bone tissue. This eliminates the need for a second removal surgery and reduces long-term risks associated with permanent foreign materials. The company has received regulatory approvals in Europe, India, Malaysia, Myanmar, Singapore, and has been recognized with several industry awards. At least one product has received FDA Breakthrough Device designation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Syntellix.